SLHGF Skylight Health Group Inc. (PNK) volume spike 11 Feb 2026: check liquidity

A sudden volume-spike flag hit SLHGF stock on 11 Feb 2026, putting Skylight Health Group Inc. (SLHGF) in focus during market hours. The tic shows a quoted price near $0.00010 USD on the PNK (United States) tape with reported average volume of 3.00 shares. Our volume-spike screen flagged a high relative-volume metric even though reported intraday prints remain thin. This signals heightened interest and potential short-term volatility, so traders should weigh liquidity constraints against any entry or exit plans.

What triggered the volume spike signal

Meyka’s scanner picked SLHGF stock because the relative-volume metric reads 13,333.33 versus an average of 3.00 shares. One clear claim: a large relative-volume ratio created an alert even with a nominal official volume print. We note that reported intraday volume can lag or understate OTT activity in micro-cap names, so the spike likely represents bursts of interest or odd-lot activity rather than institutional block trades.

Fundamental snapshot and valuation

Skylight Health Group Inc. operates in Healthcare (Medical – Care Facilities) and reports a trailing EPS of -5.00 and a market cap near $3,982.00 USD. One clear claim: key ratios show very low price multiples by market quotation (P/S ~0.00020, P/B ~0.00013) but these reflect an ultra-low quoted price, not improved fundamentals. The company shows negative net income and negative operating cash flow per share, while book value per share stands at 1.03 USD.

Technical setup and trading considerations for SLHGF stock

One clear claim: technical indicators are mixed. The Relative Strength Index reads about 59.46, and ADX at 70.48 signals a strong trend signal in the dataset, yet volume data is irregular. Price averages show a 50-day mean near 0.00007 USD and a 200-day mean near 0.00002 USD. Given ultra-low liquidity, bid-ask spreads and execution risk are primary concerns for active traders.

Meyka AI rates SLHGF with a score out of 100

Meyka AI rates SLHGF with a score out of 100: 62.77 (Grade: B) and the platform suggests HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. One clear claim: the grade is a composite signal, not a recommendation. These proprietary grades aim to help investors compare names across the healthcare sector.

Meyka AI forecast and price targets

Meyka AI’s forecast model projects a three-year price near $0.02113 USD, a five-year level near $0.04993 USD, and a seven-year level near $0.08836 USD. One clear claim: compared with the current quote $0.00010 USD, those model outputs imply very large percentage moves: short-term tactical target $0.00050 USD (implied upside 300.00%), 12-month $0.00500 USD (implied upside 4,900.00%), and three-year $0.02113 USD (implied upside 21,033.74%). Forecasts are model-based projections and not guarantees.

Risks, catalysts and sector context

One clear claim: risk is high. SLHGF stock faces limited liquidity, negative earnings, and micro-cap execution risk. Catalysts could include the company’s upcoming earnings announcement on 25 Feb 2026, any contract wins in the U.S. primary care network, or regulatory developments for telemedicine. In sector context, healthcare demand remains steady but investor interest shifts to scalable, profitable models; Skylight’s subscription telemedicine model is an opportunity but needs margin improvement to alter fundamentals.

Final Thoughts

Key takeaway: SLHGF stock is a high-risk, high-noise micro-cap flagged by a volume-spike screen on 11 Feb 2026. The current quote sits near $0.00010 USD on the PNK (United States) exchange with an official market cap near $3,982.00 USD and only 3.00 average daily shares reported. Meyka AI’s forecast model projects a three-year target of $0.02113 USD, implying an upside of roughly 21,033.74% versus the current quote. Traders should treat the signal as an interest alert, not a trade instruction. For execution, use limit orders, small sizes and confirm prints on multiple venues because quoted liquidity is thin. Remember, Meyka AI provides data-driven signals and a proprietary grade (B / HOLD) to support due diligence. Forecasts are model-based projections and not guarantees. For company details see Skylight Health Group and the security image and profile FinancialModelingPrep.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.